Francesco Paneni is Prof. Dr. med. at Zurich University Hospital, Cardiologist, and Head of Cardiovascular Epigenetics Lab. Francesco Paneni was born on October 20, 1981 in Rome, Italy. Dr. Paneni obtained his MD degree in 2006 and then started his clinical training in Cardiology at the University of Rome “Sapienza”. In 2005 he spent 4 months at Mount Sinai Medical Centre in New York, where he obtained a first-level master in cardiac CT and MRI. In July 2011, he fulfilled all the requirements for Board Certification in Cardiology. In 2014, he obtained the Ph.D. in Experimental Medicine at the University of Rome “Sapienza”. From 2011 to 2013 he worked as Research Associate in the Cardiovascular Research team of Prof. Luscher at the University of Zurich, Switzerland. From 2014 to 2017, Dr. Paneni has worked as Research Associate at the Unit of Cardiology and Center for Molecular Medicine, Karolinska Institute. On January 2017, he was appointed Assistant Professor and Research Group Leader at the University of Zurich, in the Centre for Molecular Cardiology. A main focus of Paneni’s lab is to characterize the epigenetic landscape, molecular phenotype and functionality of circulating angiogenic cells in aging and type 2 diabetes. He is author of 86 peer-reviewed articles (H index: 28, total impact factor: 590), with many of them published in highly ranked Journals. Dr. Paneni won competitive international awards [ESC Young Investigator Award in Basic Science (2012); Circulation Research Best Manuscript Award (2013); ESC Young Investigator Award in Basic Science (2014); ATVB Outstanding Research Award by the American Heart Association (2014), ESC Best of Basic Science (2015), ESC Best Moderated Poster (2016)]. He is reviewer for several peer-reviewed Journals, past member of the European Society of Cardiology (ESC) Credential Committee and remote reviewer for the European Research Council (ERC). He is fellow of the ESC (FESC) and Associate Editor of two major Cardiovascular Journals. Finally, he obtained several internal and extramural fundings as Principal and co-Principal Investigator.